Rizvi Qasim 4
4 · Kiniksa Pharmaceuticals, Ltd. · Filed Sep 14, 2020
Insider Transaction Report
Form 4
Rizvi Qasim
Chief Commercial Officer
Transactions
- Award
Share Option
2020-09-10+75,000→ 75,000 totalExercise: $15.50Exp: 2030-09-09→ Class A Common Shares (75,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is September 10, 2020.